Showing results (61-70 of 116) with videos related to
Sort By:
Pageof 12
Journal of Neuro-Oncology|June 20, 2024
Effects of tumor treating fields (TTFields) on human mesenchymal stromal cellsMaren Strack, Jan Kückelhaus, Martin Diebold, et al.Clinical and Translational Radiation Oncology|March 4, 2022
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiationAlexander Rühle, Anca-L Grosu, Nicole Wiedenmann, et al.Radiation Oncology (London, England)|March 3, 2024
Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junctionTilman Bostel, Eirini Nikolaidou, Daniel Wollschläger, et al.Stem Cell Research|August 23, 2019
Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapyRamon Lopez Perez, Franziska Münz, Denise Vidoni, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 22, 2024
German radiation oncology's next generation: a web-based survey of young biologists, medical physicists, and physicians-from problems to solutionsThomas Weissmann, Lisa Deloch, Maximilian Grohmann, et al.Journal of Medical Internet Research|October 19, 2023
App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled TrialTanja Sprave, Michelle Pfaffenlehner, Raluca Stoian, et al.Cancer Medicine|December 29, 2025
Quality of Life and Return to Work After Radiotherapy in Young Adults With Head-and-Neck Cancer-A Bicentric Cross-Sectional Observational StudyCharlotte Pannenbecker, Clemens Seidel, Jiadai Zou, et al.International Journal of Molecular Sciences|July 27, 2022
Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell CarcinomaAlexander Rühle, Marie Lies, Maren Strack, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2020
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancerNicole Wiedenmann, Anca-Ligia Grosu, Martin Büchert, et al.Frontiers in Oncology|June 24, 2022
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate CancerSimon K B Spohn, Viktoria Birkenmaier, Juri Ruf, et al.Pageof 12